quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:23:07·30d
ANALYSTRating
Terns Pharmaceuticals Inc. logo

Terns Pharmaceuticals downgraded by H.C. Wainwright

TERN· Terns Pharmaceuticals Inc.
Health Care
Original source

Companies

  • TERN
    Terns Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Mar 25UpdateH.C. Wainwright-
  • Feb 9UpdateLeerink Partners$58.00
  • Nov 4UpdateH.C. Wainwright$20.00
  • Nov 3UpdateWilliam Blair-
  • Oct 15UpdateTruist$20.00
  • Sep 17UpdateBarclays$15.00

Related

  • SEC5h
    Amendment: SEC Form SC 14D9/A filed by Terns Pharmaceuticals Inc.
  • SEC5h
    Amendment: SEC Form SC TO-T/A filed by Terns Pharmaceuticals Inc.
  • PR6h
    Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
  • PR17d
    Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.
  • SEC17d
    SEC Form SC 14D9 filed by Terns Pharmaceuticals Inc.
  • SEC17d
    SEC Form SC TO-T filed by Terns Pharmaceuticals Inc.
  • INSIDER21d
    SEC Form 4 filed by Kuriakose Emil
  • PR21d
    Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022